Disruption of this junction-associated SEPT9 cytoskeleton, as observed in patients with IBD, likely contributes to gut barrier dysfunction and exacerbated mucosal inflammation, hallmarks of these diseases. This evidence concerns the gene SEPTIN9 and inflammatory bowel disease.